Quoin Pharmaceuticals, Ltd.
QNRX
$6.63
$0.030.46%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.18% | -0.73% | 15.02% | 18.36% | 7.41% |
| Total Depreciation and Amortization | -3.57% | -3.17% | -2.21% | -1.25% | -0.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 61.69% | -28.73% | -53.10% | -61.38% | -30.09% |
| Change in Net Operating Assets | -102.20% | -289.79% | -299.09% | -78.55% | 201.16% |
| Cash from Operations | 0.09% | -34.35% | -5.71% | 7.15% | 7.27% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -186.29% | 963.29% | 112.88% | 108.93% | 121.56% |
| Cash from Investing | -186.29% | 963.29% | 112.88% | 108.93% | 121.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 34.19% | 7.84% | 24.57% | 34.19% |
| Issuance of Common Stock | 97.76% | -6.03% | -73.52% | -73.58% | -60.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -177.62% | -177.62% | -177.62% | -177.62% |
| Cash from Financing | 110.24% | -1.79% | -76.29% | -75.89% | -62.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 366.02% | 97.76% | -192.41% | 15.36% | 90.06% |